Loading...
Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study
BACKGROUND: The 3-weekly combination of trastuzumab and paclitaxel has been approved for the treatment of advanced breast cancer based on a large pivotal study. However, mono and combination chemotherapy trials suggest that weekly paclitaxel has a better therapeutic index, especially in the palliati...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3443018/ https://ncbi.nlm.nih.gov/pubmed/22559145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-165 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|